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ABSTRACT 
Development of a 1-Hydroxypyrene Quantification Method for Use as a Biomarker in 
Assessment of Polycyclic Aromatic Hydrocarbon Exposure 
  
 
Allison Van Cleve 
Department of Chemistry 
Texas A&M University 
 
Research Advisor: Dr. Natalie Johnson 
Department of Environmental and Occupation Health 
Texas A&M University 
 
 
A common phenolic metabolite of pyrene, 1-hydroxypyrene (1-OHP), is often used as a 
biomarker to assess polycyclic aromatic hydrocarbon (PAH) exposure. The developed high-
performance liquid chromatography with mass spectrometry (LC-MS/MS) method showed 
sufficient sensitivity to quantify 1-OHP in non-smoker urine samples, obtained in an ongoing 
project studying the effects of traffic related air pollution exposure in a population of pregnant 
women in South Texas. Data obtained through the developed method will be used to assess the 
effectiveness of 1-OHP as a biomarker for PAH exposure and will be compared to urinary 
concentrations of nitrated pyrene metabolites and airborne pyrene concentrations, collected 
through the use of personal monitoring devices. Success of the project will be determined by the 
specificity and sensitivity of the proposed method in quantification of 1-OHP concentrations and 
its application to the overall aims of the ongoing project.  
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NOMENCLATURE  
 
ATSDR Agency for Toxic Substances and Disease Registry 
B(a)P  Benzo(a)pyrene 
CDC  Center for Disease Control and Prevention 
DI  Deionized 
EPA  U.S. Environmental Protection Agency 
GC/MS Gas Chromatography with Mass Spectrometry 
HPLC  High Performance Liquid Chromatography  
IRAC  International Agency for Research on Cancer 
1-OHP  1-Hydroxypyrene 
1-OHP-G 1-Hydroxypyrene-Glucuronide 
OHNP  Hydroxynitropyrene 
LC-MS/MS Liquid Chromatography with Tandem Mass Spectrometry 
PAH  Polycyclic Aromatic Hydrocarbon  
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CHAPTER I 
INTRODUCTION 
 
Polycyclic aromatic hydrocarbons (PAHs) are a class of environmental containments that 
are produced through the incomplete combustion of organic matter, detected most abundantly in 
sources of diesel exhaust, cigarette smoke, and wood smoke.1 Specific PAHs, such as 
benzo(a)pyrene and 1-nitropyrene, have been identified by the International Agency for Research 
on Cancer (IRAC) as known (Group 1) and probable (Group 2A) carcinogens, respectively.2 
Furthermore, PAHs have been listed as priority hazardous substances by the Agency for Toxic 
Substances and Disease Registry (ATSDR),3 and as priority pollutants by the U.S. Environmental 
Protection Agency (EPA).4  
PAH exposure can occur through methods of inhalation, ingestion, and dermal 
absorption.5 This exposure can be quantified through the analytical study of specific urinary PAH 
metabolites. For example, in a study conducted by the Center for Disease Control and Prevention 
(CDC), concentrations of phenolic metabolites of fluorine, phenathrene, naphthalene and pyrene 
(2,3,9-hydroxyfluorene, 1,2,3,4-hydroxyphenanthrene, 1,2-hydroxynaphthalene, and 1-
hydroxypyrene, respectively) were measured in urine samples of smokers and nonsmokers. 
Concentrations of these metabolites were found to be higher among the population of smokers, 
supporting the correlation of increased PAH exposure with greater exposure to cigarette smoke.1 
Among the many PAH urinary metabolites, monohydroxylated PAHs have been commonly used 
as biomarkers in prior studies to assess the extent of PAH exposure in populations.5 1-
hydroxypyrene (1-OHP) is frequently used as both a single biomarker and in a series of 
biomarkers, and is favored due to higher levels of detection in urine samples in comparison to 
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other metabolites. Such studies have achieved quantification of 1-OHP through analytical 
techniques including gas chromatography, liquid chromatography, and high-performance liquid 
chromatography (HPLC) with fluorescence detection, or more recently, HPLC separation 
followed by mass spectrometry.6  
The aim of this project was to develop an analytical method to quantify 1-OHP 
concentrations in urine samples with high specificity and sensitivity using liquid chromatography 
with tandem mass spectrometry (LC-MS/MS), incorporating isotopic 1-OHP as an internal 
standard.  This method was then applied to determine overall PAH exposure, based on the 1-
OHP biomarker, in a population of pregnant women residing in South Texas.   
Chemical properties of PAHs 
PAHs are a large class of organic compounds composed of two or more fused aromatic 
rings, consisting of primarily carbon and hydrogen.7 Compounds may contain various 
substituents, such as alkyl, amino, halogen, hydroxyl, or thiol groups. Heterocyclic derivatives of 
PAHs contain one or more heteroatoms, such as nitrogen, oxygen or sulfur, within the atomic 
structure.8 PAH molecules are characterized by aromaticity, or an increased stability due to the 
resonance of delocalized π-electrons within the molecule.9 Structural examples of various 
homocyclic PAHs are shown in Figure 1.  
The physical properties of PAHs vary with both structure and molecular weight, but 
generally, PAHs are characterized as colored, crystalline solids at room temperature with high 
stability, low volatility, and low solubility in water.7,10 Most notably, solubility and vapor 
pressure both decrease with increased molecular weight or number of rings.11 As a result, low 
molecular weight compounds with less than 4 conjugated rings, such as naphthalene, have 
increased volatility and exist primarily in the gas phase.7,12 An exception to this solubility trend 
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occurs in high molecular weight compounds (4 or more rings), in which compounds adopt a non-
planar conformation to reduce steric strain. In these instances, polarity, and therefore solubility in 
water, is increased.11  
 
Figure 1. Chemical structures of homocyclic PAHs with varying molecular weights and 
arrangements. 
Although lighter PAHs are considered to have weaker carcinogenic and mutagenic 
properties, they are likely to react with other atmospheric pollutions, such as nitrogen oxides, to 
form compounds with increased toxicity when in the gas phase.7,12 Such substituted PAHs can be 
beneficial in tracking compounds from specific sources, such as the nitrogenation of 1-OHP in 
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the presence of nitrogen dioxide from diesel exhaust to form isomers of hydroxynitropyrene 
(OHNP), shown in Figure 2.13  
 
Figure 2. Chemical structure of 3, 6, and 8-OHNP. 
Sources of PAHs 
 PAHs are emitted into the environment as air, soil, and water pollutants through the 
combustion of organic matter from both natural and anthropogenic sources. While natural origins 
such as forest fires and volcanic eruptions contribute to total environmental PAH levels, 
anthropogenic origins are considered to yield the largest contribution. Such sources include 
burning of wood or fossil fuels for heat or power generation, garbage incineration, cooking, and 
vehicular traffic emissions.7,9,12 Although PAHs are present in the environment globally, they are 
found in the highest concentrations near urban centers. It should be noted that levels in urban 
environments vary depending on factors such as population density, types of emission sources, 
meteorological conditions, and temperature. Additionally, concentrations tend to be higher 
during the winter as a result of increased fuel combustion for residential heating.9,12 
 
8 
Exposure to PAHs 
Major routes of PAH exposure to the general population include inhalation of ambient 
and indoor air pollution, smoking cigarettes or tobacco, and cooking and consumption of food.li 
Workers in industries such as transportation, manufacturing and oil refinery risk higher rates of 
PAH exposure, which has been correlated with increased occurrences of skin and lung cancers as 
well as other adverse health effects.12,14 In non-smoking individuals, primary routes of exposure 
include cooking emissions and consumption of food, particularly if it has been grilled or fried.7  
Exposure in both humans and animals can also occur through ingestion of uncooked foods, such 
as lettuce, tomatoes, and kale, especially when were grown in proximity to a source of pollution, 
such as a highway. PAH content in such plants occurs due to a combination of particle-phase 
deposition of PAHs onto leaves and absorption of PAHs in contaminated soil. Concentrations 
vary depending on the extent of exposure, atmospheric conditions, and the biological properties 
of the plant.12 
Health effects of PAHs 
 Adverse health effects due to PAH exposure vary depending on factors such as extent of 
exposure, PAH toxicity properties, and the route of exposure, such as inhalation, ingestion, or 
dermal absorption. Age and previously existing health conditions, such as asthma or coronary 
heart disease, may also affect the severity of health impact. Acute non-carcinogenic effects of 
exposure include eye and skin irritation, allergic reactions, nausea, and vomiting.15,16 Chronic 
non-carcinogenic health effects, generally reported due to long-term occupational exposure, 
include kidney and liver damage and related diseases such as jaundice, cataracts, reproductive 
health complications, and breakdown of red blood cells.7,12 
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 The carcinogenic effects of PAH exposure vary with the aforementioned factors as well 
as the extent of exposure to certain compounds. Specifically, eight PAH compounds have been 
identified by the EPA and other agencies as probable human carcinogens: benz(a)anthracene, 
benzo(a)pyrene, benzo(b)flyoranthene, benzo(k)fluoranthene, chrysene, dibenze(a,h)anthracene, 
indeno(1,2,3-c,d)pyrene, and benzo(ghi)perylene.3,4,7 Of these, benzo(a)pyrene (B(a)P) is widely 
considered to be highly carcinogenic.12,17 Reported carcinogenic effects of PAH exposure, 
generally occurring due to occupational exposure, include skin, lung, and stomach cancers.7 
Biomarkers of PAHs 
 Following PAH exposure by inhalation, ingestion, or dermal absorption, PAHs can be 
biotransformed by either phase I or phase II metabolic enzymes to form hydroxylated derivatives 
and glucuronic acid or sulfate conjugates, respectively. Metabolized forms, such as 1-OHP, and 
PAH-DNA or protein adducts have increased aqueous solubility and are primarily excreted in 
urine. While PAH exposure can be assessed by methods such as external monitoring and blood 
analysis, urinary metabolites can be measured in a non-invasive manner with increased 
accessibility.10 Such assessment is useful in identification of individuals with recent occupational 
or environmental exposure, determination of specific routes and sources of exposure, and 
correlation of extent of exposure with adverse health effects.18 
1-OHP and 1-hydroxypyrene-glucuronide (1-OHP-G) are most commonly used as 
biomarkers to assess recent exposure to both general PAH mixtures and specific compounds of 
interest, such as B(a)P.18,19 The wide success and applicability of 1-OHP as a biomarker is 
largely due to the high concentrations of pyrene (2-10%) of all environmental mixtures of 
PAHs,7  and the occurrence of 1-OHP as the primary product of the metabolization of pyrene 
(90% likelihood of formation).19 Molecular structures of pyrene and 1-OHP are given in Figure 
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3. Formation of 1-OHP-G is also highly favored (80% likelihood of formation) and is often 
favored to assess low exposure to PAHs, due to its high fluorescence.10,18 
1-OHP as a major pyrene metabolite was first observed in pig urine by Keimig et al. in 
1983, and first proposed as a biomarker for assessing PAH exposure by Jongeneelen et al. in 
1987.20-22 This method used HPLC with fluorescence detection to correlate concentrations of 1-
OHP in the urine of rats following oral administration of pyrene in varying doses, and to assess 
occupational PAH exposure from creosote.21 Since then, 1-OHP has been used in numerous 
studies to assess the extent PAH exposure in various populations using methods such as HPLC 
with fluorescence detection, gas chromatography with mass spectrometry (GC/MS), and more 
recently, LC-MS/MS.10,17,19,22,23  
 
Figure 3. Chemical structures of pyrene and its primary urinary metabolite, 1-OHP. 
  
11 
CHAPTER II 
METHODS 
 
Materials 
 Authentic 1-hydroxypyrene (1-OHP) reference standard, pyrene-d10 and β-
glucuronidase/aryl sulfatase (from Helix pomatia) were purchased from Sigma-Aldrich (St. 
Louis, MO). Blue rayon was purchased from Funakoshi (Tokyo, Japan). Solid phase extraction 
cartridges were purchased from Waters (Milford, MA). All of the experiments were done suing 
filtered and deionized (DI) water (18.2 MΩ cm) (Millipore, Milford, MA). All other chemicals 
and reagents were purchased commercially at the highest degree of purity available.  
Synthesis 
1-OHP-d9 (for use as an internal standard) was synthesized according to a published 
method developed by Toriba et al.13 The concentration of 1-OHP-d9 was determined using UV-
Visible spectrophotometry.  
Urine sample preparation and extraction 
1-OHP was extracted from human urine according to a method developed by Toriba et al. 
with modifications.13 The collection of human urine and study population is described in detail 
below. Briefly, a 100 mL aliquot of each urine sample was thawed at room temperature. The pH 
was adjusted to 5.0 with 1.0 M HCl. 5 mL of 4 M acetate buffer (pH 5.0) and 75 µL β-
glucuronidase was added to the sample prior to incubation (37 °C, 4 h) with gentle agitation.  
Following incubation, 100 mg of blue rayon was added to increase the sorption of 1-OHP, and 
the sample was incubated (1 h) at room temperature with agitation by shaker (60 rpm). The blue 
rayon was removed from the liquid phase, washed with 5 mL DI water, and allowed to air dry (3 
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min). The blue rayon was extracted with 20 mL MeOH:Ammonia (50/1, v/v) with aid of 
sonication (30 min). The blue rayon was removed from the sample and discarded. The liquid 
phase was dried under nitrogen and re-suspended in 5 mL MeOH:EtAc (1/1, v/v). The sample 
was applied to a Sep-Pak Alumina A cartridge, (Waters, Milford, MA) preconditioned with 50 
mL MeOH:EtAC. The sample was eluted with 10 mL MeOH:EtAc. The elutant was dried under 
nitrogen and re-dissolved in 500 µL HPLC grade methanol. The sample was separated into 250 
µL aliquots for 1-OHP and saved for later analysis of nitrated OHP metabolites. The samples 
designated for 1-OHP analyses were spiked with 20 µL of internal standard, 200 ng/mL 1-OHP-
d9.   
Analysis of 1-OHP by LC-MS/MS 
 A Waters Acquity H-Class UPLC system coupled with a Thermo triple quadruple mas 
spectrometer was used for 1-OHP sample analyses. Separation was performed on a Zorbax 
SSHD Eclipse Plus-C18 column (3.0 x 50 mm, 1.8 µm; Agilent, Santa Clara, CA) with a guard 
column (2.1x 5 mm, 1.8 µm; Agilent, Santa Clara, CA) at 25 °C. A gradient elution of 0.1% 
ammonium acetate in water (eluent A) and HPLC grade methanol (eluent B) was used at a flow 
rate of 0.4 mL/min, based on methods reported by Ramsauer et al.6 Sample volumes of 10 µL 
were injected for each analysis. The observed retention times and mass transitions are given in 
Table 1. 
Table 1. Observed retention times and mass transitions of 1-OHP and 1-OHP-d9 
Analyte RT (min) Parent ion (m/z) Daughter ion (m/z) 
1-OHP 4.7 217 189 
1-OHP-d9 4.7 226 198 
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Study population and urine collection 
 1-OHP levels were measured as part of an ongoing study to assess exposure to air 
pollution in a population in Hidalgo County, shown to be at high risk for asthma development. 
This location was chosen for the study because it has been reported to have one of the highest 
rates of hospitalization due to childhood asthma, at 14.82%, in the state of Texas.24 The overall 
goal of this study was to determine air pollution exposure in pregnancy since prenatal air 
pollution exposure is an emerging risk factor for childhood asthma development.28,29 
Study population 
 The study population consisted of 17 women in their third trimester of pregnancy that 
received prenatal care from Rio Grande Regional Women’s Clinic. And met all other inclusion 
criteria. All participants provided written and informed consent. All study procedures were 
approved by the Texas A&M University Institutional Review Board and access to participant 
identifiable data was restricted. Participants were between 21 and 35 years of age, had no history 
of preterm birth, were non-asthmatic and non-diabetic, lived in a non-smoking household, and 
had a singleton pregnancy. Specific demographic information is provided in Table 2. 
Sample collection 
 Urine samples were obtained from the study population in three-week intervals between 
June 2015 and April 2016. Samples were collected at Rio Grande Regional Women’s Clinic 
during the participant’s regularly scheduled prenatal care appointments. Participants were 
instructed to collect their first void on the day of their appointment in a provided sterilized 120 
mL plastic urine container. Samples were kept on ice during transportation. Upon laboratory 
receipt, urine volume was recorded and samples were diluted with deionized water to reach a 
final volume of 100 mL, if needed. A 5mL aliquot was designated from each sample for 
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creatinine analysis. The sample remainders were stored in polypropylene tubes at -80ºC until 
analysis.  
Table 2.  Population demographic information.25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Criterion N % 
Ethnicity   
Hispanic  17 100 
Education Level   
Less than 12 years 7 41 
12 years 6 35 
More than 12 years 1 6 
Unknown 3 18 
   Smoking History   
Never 12 71 
Before Pregnancy 2 12 
Unknown 3 18 
   Type of Home   
Single Family Home - Detached 7 41 
Single Family Home - Attached 1 6 
Mobile Home 5 29 
Unknown 4 24 
   Heating System   
Central Heating 4 24 
Single Stoves/Heaters 3 18 
Electric 7 41 
Gas 0 0 
Unknown 3 18 
   Cooling System   
Central Air Conditioning 5 29 
Window Units 6 35 
None 1 6 
Unknown 5 29 
   Primary Cooking Method   
Electric 5 29 
Gas 9 53 
No Cooking at Home 1 6 
Unknown 2 12 
Employment   
Yes 2 12 
No 15 88 
15 
During the third sampling period, hair follicle samples were collected to assess and 
confirm limited exposure to cigarette smoke by nicotine analysis. An isotope dilution GC/MS 
method developed by Kim et al. was used to determine nicotine concentrations.26,27 Of the 
samples analyzed, 7 concentrations were found to be below the limit of detection, 0.0492 ng/mg, 
with the remaining 10 concentrations below 0.062 ng/mg. Low nicotine concentrations indicated 
that all of the study participants were not regularly exposed to second hand smoke and therefore, 
remained in the study.25  
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CHAPTER III 
RESULTS AND DISCUSSION 
 
Urinary concentrations of 1-OHP 
Urinary concentrations of 1-OHP (ng/mL) were calculated from the generated calibration 
curve (Figure 4) using the obtained 1-OHP:1-OHP-d9 peak ratios. To generate this standard 
curve, authentic human urine samples (with low 1-OHP background) were spiked with the 1-
OHP and 1-OHP-d9 standards and processed as described in the methods above.1-OHP standards 
were prepared in methanol and spiked into urine to yield the following concentrations: 0.0, 1.0, 
2.0, 4.0, 8.0, 16.0, 32.0, and 50.0 ng/100 mL. 1-OHP concentrations were confirmed by UV-VIS 
spectroscopy absorbance at 242 nm with a molar absorptivity of 63096 L mol-1 cm-1.30   All 
samples were spiked with 20 µL of the internal standard (200 ng/mL 1-OHP-d9).  
 
Figure 4. Calibration curve for calculation of 1-OHP concentration in urine samples.  
 
y = 0.0647x + 0.1752 
R² = 0.9985 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
0 10 20 30 40 50 60 
1-
O
H
P/
1-
O
H
P-
d9
 
1-OHP ng/100 mL urine 
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 1-OHP was detected in 88% of the samples at a limit of detection (LOD) of 0.01 ng/mL 
urine. Individual concentration values were normalized by respective creatinine concentrations 
(mg/dL) to determine the final urinary concentration of 1-OHP (ng/mg crt.). Concentration 
values are shown in Table 3. Values were in range of those in previously published studies.6   
Table 3. Urinary concentrations of 1-OHP in study population. 
1-OHP Mean ± standard deviation, median (range) 
ng/mL  0.079 ± 0.073, 0.054 (0.012-0.398) 
ng/mg crt.  0.310 ± 0.395, 0.213 (0.036-2.082) 
 
Chromatograms 
 Chromatograms for LC-MS/MS analysis of 1-OHP in blank and participant urine 
samples are given in Figures 5 and 6, respectively. Isotopic mass transitions for 1-OHP and 1-
OHP-d9 are shown on the graphs.  
It should be noted that in a preliminary concentration analysis, the internal standard 
spiked prior to urine extraction was unable to be detected at our LOD. Extracted urine samples 
were therefore respiked with a higher concentration of 1-OHP-d9, which was detected in 88% of 
the samples at the LOD. This method could lead to inaccuracy of the 1-OHP to 1-OHP-d9 ratio, 
as the internal standard did not undergo the same work up procedure. In future applications of 
this method, it is suggested to spike the internal standard prior to sample incubation with blue 
rayon. 
18 
 
Figure 5. Chromatograms for 1-OHP and 1-OHP-d9  spiked in a blank urine sample. 
 
Figure 6. Chromatograms for 1-OHP and 1-OHP-d9 in participant urine sample. 
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CHAPTER IV 
CONCLUSION 
 	 Results	illustrate that the majority of the study population had a measurable exposure to 
PAHs. 1-OHP levels measured in this population of non-smoking women were similar to those 
previously recorded for non-smoking individuals in numerous countries. For instance, the 
median 1-OHP level measured in non-smokers at baseline in our study population (0.054 ng/mL) 
is similar to 1-OHP concentrations measured in non-smokers from the U.S. (0.0505 ng/mL).6 
The relatively low levels of urinary 1-OHP measured in study participants suggest that 
inhabitants are exposed to background doses of PAHs likely from traffic or the indoor 
preparation of foods or ingestion of grilled or smoked foods.   
In summary, the proposed method has sufficient sensibility for quantification of 1-
hydroxypyrene in urine samples. This method and its results will be applied to other aspects of 
the ongoing population study, such as concentration of nitrated pyrene metabolites in urine 
samples as a benchmark of traffic related air pollution exposure. 
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